Nasdaq Stockholm Welcomes Gabather to First North
(WorldNews Denmark)

Nasdaq Nordic Nasdaq Stockholm Welcomes Gabather to First North Stockholm, April 16, 2018- Nasdaq (Nasdaq: NDAQ) announces that the trading in Gabather AB`s shares (short name: GABA) will commence today on Nasdaq First North in Stockholm. Gabather belongs to the health care sector and is the 22nd company to be admitted to trading on Nasdaq`s Nordic markets* in 2018. Founded in 2014, Gabather is a Swedish health care company developing novel drug candidates for treatment of several diseases originating in the central nervous system (CNS). The company focuses on four main areas: Anti-psychotics, Anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments,...